Archives of Pediatric Infectious Diseases

Published by: Kowsar
Crossmark

Molecular Identification of Gram-Negative Bacteria in Respiratory Samples of Cystic Fibrosis Patients from a Children Referral Hospital in Tehran

Leila Azimi 1 , Roxana Mansour Ghanaiee 1 , * , Mehdi Shirdust 1 , Ahmad Moein Karimi 2 , Shahnaz Armin 1 , Sedigheh Rafiei Tabatabaei 1 , Farideh Shiva 1 , Fatemeh Fallah 1 , Mohammad Rezaei 3 , Sayyed Alireza Fahimzad 1 , Ghamartaj Khanbabaei 1 and Mohammad Rahbar 1
Authors Information
1 Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Tehran Medical Science Branch, Islamic Azad University, Tehran, Iran
3 Alborz University of Medical Sciences, Alborz, Iran
Article information
  • Archives of Pediatric Infectious Diseases: July 31, 2019, 7 (3); e64834
  • Published Online: August 3, 2019
  • Article Type: Research Article
  • Received: December 19, 2017
  • Revised: July 20, 2019
  • Accepted: July 24, 2019
  • DOI: 10.5812/pedinfect.64834

How to Cite: Azimi L, Mansour Ghanaiee R, Shirdust M , Karimi A M, Armin S , et al. Molecular Identification of Gram-Negative Bacteria in Respiratory Samples of Cystic Fibrosis Patients from a Children Referral Hospital in Tehran, Arch Pediatr Infect Dis. 2019 ; 7(3):e64834. doi: 10.5812/pedinfect.64834.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Silva Filho LV, Ferreira Fde A, Reis FJ, Britto MC, Levy CE, Clark O, et al. Pseudomonas aeruginosa infection in patients with cystic fibrosis: Scientific evidence regarding clinical impact, diagnosis, and treatment. J Bras Pneumol. 2013;39(4):495-512. doi: 10.1590/S1806-37132013000400015. [PubMed: 24068273]. [PubMed Central: PMC4075866].
  • 2. Keating C, Poor AD, Liu X, Chiuzan C, Backenroth D, Zhang Y, et al. Reduced survival in adult cystic fibrosis despite attenuated lung function decline. J Cyst Fibros. 2017;16(1):78-84. doi: 10.1016/j.jcf.2016.07.012. [PubMed: 27522311].
  • 3. Elborn JS, Vataire AL, Fukushima A, Aballea S, Khemiri A, Moore C, et al. Comparison of inhaled antibiotics for the treatment of chronic pseudomonas aeruginosa lung infection in patients with cystic fibrosis: Systematic literature review and network meta-analysis. Clin Ther. 2016;38(10):2204-26. doi: 10.1016/j.clinthera.2016.08.014. [PubMed: 27692977].
  • 4. Jenkins C, Ling CL, Ciesielczuk HL, Lockwood J, Hopkins S, McHugh TD, et al. Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: Comparison of two different approaches in clinical practice. J Med Microbiol. 2012;61(Pt 4):483-8. doi: 10.1099/jmm.0.030387-0. [PubMed: 22160310].
  • 5. Cigana C, Melotti P, Baldan R, Pedretti E, Pintani E, Iansa P, et al. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. BMC Microbiol. 2016;16(1):142. doi: 10.1186/s12866-016-0760-1. [PubMed: 27400750]. [PubMed Central: PMC4940697].
  • 6. Rocha GA, Ferreira AG, Lima DF, Leao RS, Carvalho-Assef AP, Folescu TW, et al. Draft genome sequence of Acinetobacter pittii ST643 shared by cystic fibrosis patients. Mem Inst Oswaldo Cruz. 2016;111(9):592-3. doi: 10.1590/0074-02760160142. [PubMed: 27653362]. [PubMed Central: PMC5027864].
  • 7. Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Drug Resist Updat. 2016;28:82-90. doi: 10.1016/j.drup.2016.07.003. [PubMed: 27620956]. [PubMed Central: PMC5022785].
  • 8. de Souza Carraro D, Carraro RM, Campos SV, Iuamoto LR, Braga KAO, Oliveira LC, et al. Burkholderia cepacia, cystic fibrosis and outcomes following lung transplantation: Experiences from a single center in Brazil. Clinics (Sao Paulo). 2018;73. e166. doi: 10.6061/clinics/2018/e166. [PubMed: 29538493]. [PubMed Central: PMC5840825].
  • 9. Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, Buer J, Rath PM, Steinmann J. Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance. J Cyst Fibros. 2011;10(6):422-7. doi: 10.1016/j.jcf.2011.06.010. [PubMed: 21763218].
  • 10. Johnson EJ, Zemanick ET, Accurso FJ, Wagner BD, Robertson CE, Harris JK. Molecular identification of Staphylococcus aureus in airway samples from children with cystic fibrosis. PLoS One. 2016;11(1). e0147643. doi: 10.1371/journal.pone.0147643. [PubMed: 26808658]. [PubMed Central: PMC4726467].
  • 11. Pattison SH, Rogers GB, Crockard M, Elborn JS, Tunney MM. Molecular detection of CF lung pathogens: Current status and future potential. J Cyst Fibros. 2013;12(3):194-205. doi: 10.1016/j.jcf.2013.01.007. [PubMed: 23402821].
  • 12. Xu J, Moore JE, Murphy PG, Millar BC, Elborn JS. Early detection of Pseudomonas aeruginosa--comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann Clin Microbiol Antimicrob. 2004;3(21):1-5. doi: 10.1186/1476-0711-3-21. [PubMed: 14713319]. [PubMed Central: PMC529303].
  • 13. Anbazhagan D, Mui WS, Mansor M, Yan GO, Yusof MY, Sekaran SD. Development of conventional and real-time multiplex PCR assays for the detection of nosocomial pathogens. Braz J Microbiol. 2011;42(2):448-58. doi: 10.1590/S1517-83822011000200006. [PubMed: 24031653]. [PubMed Central: PMC3769846].
  • 14. Khorsi K, Messai Y, Hamidi M, Ammari H, Bakour R. High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian Pac J Trop Med. 2015;8(6):438-46. doi: 10.1016/j.apjtm.2015.05.011. [PubMed: 26194827].
  • 15. Clarke L, Moore JE, Millar BC, Garske L, Xu J, Heuzenroeder MW, et al. Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients. J Med Microbiol. 2003;52(Pt 9):759-63. doi: 10.1099/jmm.0.05077-0. [PubMed: 12909651].
  • 16. Bauernfeind A, Schneider I, Jungwirth R, Roller C. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol. 1999;37(5):1335-9. [PubMed: 10203482]. [PubMed Central: PMC84768].
  • 17. Bittar F, Rolain JM. Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients. Clin Microbiol Infect. 2010;16(7):809-20. doi: 10.1111/j.1469-0691.2010.03236.x. [PubMed: 20880410].
  • 18. Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, Sarles J, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One. 2008;3(8). e2908. doi: 10.1371/journal.pone.0002908. [PubMed: 18682840]. [PubMed Central: PMC2483419].
  • 19. Khalilzadeh S, Boloursaz M, Baghaie N, Heydarian Fard E, Hassanzad M, Emami H. Microbial colonization and drug resistance in patients with cystic fibrosis. J Compr Pediatr. 2012;3(1):25-8. doi: 10.5812/jcp.6944.
  • 20. Khanbabaee G, Akbarizadeh M, Sayyari A, Ashayeri-Panah M, Abdollahgorji F, Sheibani K, et al. A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients. Braz J Infect Dis. 2012;16(2):122-8. [PubMed: 22552452].
  • 21. Forozesh Fard M, Irajian G, Moslehi TZ, Fazeli H, Salehi M, Rezania S. Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan Al Zahra Hospital, Iran (2009-2010). Iran J Microbiol. 2012;4(2):94-7. [PubMed: 22973476]. [PubMed Central: PMC3434648].
  • 22. Deschaght P, Schelstraete P, Lopes dos Santos Santiago G, Van Simaey L, Haerynck F, Van Daele S, et al. Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients. BMC Microbiol. 2010;10:245. doi: 10.1186/1471-2180-10-245. [PubMed: 20868481]. [PubMed Central: PMC2949703].
  • 23. Moller ME, Alanin MC, Gronhoj C, Aanaes K, Hoiby N, von Buchwald C. Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review. Am J Rhinol Allergy. 2017;31(5):293-8. doi: 10.2500/ajra.2017.31.4461. [PubMed: 28859703]. [PubMed Central: PMC5590177].
  • 24. Rahal JJ, Urban C. Acinetobacter. Semin Respir Crit Care Med. 2000;21(4):341-8. doi: 10.1055/s-2000-9858. [PubMed: 16088745].
  • 25. De Luca M, Angelino G, Calo Carducci FI, Martino A, Bernardi S, Bernaschi P, et al. Multidrug-resistant Acinetobacter baumannii infection in children. BMJ Case Rep. 2011;2011. doi: 10.1136/bcr.02.2011.3807. [PubMed: 22688471]. [PubMed Central: PMC3158346].
  • 26. Eram SM, Behzadiannezhad G, Khatami GR, Nafissi N. Detection of Burkholderia cepacia complex in patients with cystic fibrosis. Tanaffos. 2004;3(9):47-52.
  • 27. Zhao J, Cheng W, He X, Liu Y. The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis. Microb Pathog. 2018;125:122-8. doi: 10.1016/j.micpath.2018.09.010. [PubMed: 30217514].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments